PRESS RELEASE published on 07/17/2026 at 23:00, 3 months 22 days ago DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales DBV Technologies files $150 million ATM prospectus with SEC for ADSs. Net proceeds to fund manufacturing expansion and product development. Forward-looking statements included Forward-looking Statements Net Proceeds SEC Filing DBV Technologies ATM Prospectus
BRIEF published on 07/16/2026 at 22:15, 3 months 23 days ago DBV Technologies publie son Rapport Financier Semestriel 2026 Rapport Financier Cotation Boursière DBV Technologies Allergies Alimentaires Technologie VIASKIN
BRIEF published on 07/16/2026 at 22:15, 3 months 23 days ago DBV Technologies Files 2026 Half-Year Report with AMF Half-year Report AMF Filing DBV Technologies Food Allergies VIASKIN Patch
BRIEF published on 07/16/2026 at 22:15, 3 months 23 days ago DBV Technologies publishes its 2026 Half-Year Financial Report Financial Report Stock Market Listing DBV Technologies Food Allergies Viaskin Technology
BRIEF published on 07/16/2026 at 22:15, 3 months 23 days ago DBV Technologies dépose son rapport semestriel 2026 auprès d'AMF. Allergies Alimentaires Rapport Semestriel Dépôt AMF Technologies DBV Patch VIASKIN
PRESS RELEASE published on 07/16/2026 at 22:10, 3 months 23 days ago DBV Technologies publie son Rapport Financier Semestriel 2026 ? Modalités de mise à disposition ou de consultation DBV Technologies publie son Rapport Financier Semestriel 2026 et le rend disponible pour consultation en ligne Investisseurs DBV Technologies Allergies Alimentaires Viaskin Rapport Financier Semestriel 2026
PRESS RELEASE published on 07/16/2026 at 22:10, 3 months 23 days ago DBV Technologies Announces the Filing of its 2026 Half-Year Report ? Conditions for Accessing or Consulting the Report DBV Technologies files 2026 Half-Year Report with French market authority AMF. Company develops treatments for food allergies with VIASKIN patch technology Half-year Report DBV Technologies Food Allergies French Market Authority VIASKIN Patch Technology
BRIEF published on 07/16/2026 at 22:06, 3 months 23 days ago DBV Technologies annonce ses résultats financiers et avancées cliniques pour le premier semestre 2026 Résultats Financiers FDA DBV Technologies Allergies Alimentaires Viaskin® Peanut
BRIEF published on 07/16/2026 at 22:06, 3 months 23 days ago DBV Technologies announces its financial results and clinical progress for the first half of 2026 FDA Financial Results DBV Technologies Food Allergies Viaskin® Peanut
BRIEF published on 07/16/2026 at 22:06, 3 months 23 days ago DBV Technologies publie son rapport financier et d'avancement de mi-année 2026 Résultats Financiers Essais Cliniques Soumission À La FDA Position De Trésorerie Patch VIASKIN® À L'arachide
Published on 11/09/2026 at 14:00, 10 minutes ago Tectonic Metals Adds Mine Development and Alaska Native Partnership Leaders Ahead of 2027 Mineral Resource Estimate and Preliminary Economic Assessment
Published on 11/09/2026 at 13:30, 40 minutes ago Meta Critical Minerals Accepts Invitation to Join Critical Minerals Consortium at the U.S. Military Academy at West Point
Published on 11/09/2026 at 13:01, 1 hour 9 minutes ago CoTec Holdings Corp. Notes HyProMag USA Advances North Texas Rare Earth Magnet Facility With First Major Equipment Delivery
Published on 11/09/2026 at 13:00, 1 hour 10 minutes ago Nextech3D.ai Closes $720,000 Management-Led Private Placement
Published on 11/09/2026 at 14:08, 1 minute ago Elmos Semiconductor SE wins “European Innovator of the Year 2026” with its Quantum Random Number Generator (QRNG)
Published on 11/09/2026 at 14:05, 4 minutes ago Royal Bank of Canada announces agreement to acquire Yarra Capital Management
Published on 11/09/2026 at 13:45, 25 minutes ago Form 8.3 - Zürcher Kantonalbank: Irish Residential Properties REIT plc
Published on 11/09/2026 at 13:35, 34 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/09/2026 at 13:05, 1 hour 4 minutes ago AUCTION OPENS FOR MICHAEL JACKSON, PRINCESS DIANA & POP CULTURE LEGENDS AS JULIEN'S HEADS TO ABU DHABI
Published on 11/09/2026 at 10:32, 3 hours 38 minutes ago Disclosure of shares outstanding and voting rights - 09.11.2026
Published on 11/09/2026 at 10:32, 3 hours 38 minutes ago Déclaration nombre d'actions et droits de vote - 09.11.2026
Published on 11/09/2026 at 07:00, 7 hours 10 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 7 hours 10 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 7 hours 10 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
